| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 56.304 | 83.560 | 108.764 | 110.674 |
| Total Income - EUR | - | - | - | - | - | - | 57.194 | 83.821 | 108.902 | 110.739 |
| Total Expenses - EUR | - | - | - | - | - | - | 19.395 | 45.185 | 45.186 | 123.962 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 37.799 | 38.636 | 63.716 | -13.223 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 36.141 | 36.997 | 62.759 | -15.395 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Pharmaprix Distribution S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 626 | 3.287 | 2.151 | 1.121 |
| Current Assets | - | - | - | - | - | - | 201.125 | 226.943 | 253.616 | 348.815 |
| Inventories | - | - | - | - | - | - | 15.412 | 43.761 | 58.459 | 59.765 |
| Receivables | - | - | - | - | - | - | 153.784 | 157.087 | 159.801 | 168.134 |
| Cash | - | - | - | - | - | - | 31.930 | 26.096 | 35.356 | 120.916 |
| Shareholders Funds | - | - | - | - | - | - | 36.135 | 73.244 | 135.822 | 36.204 |
| Social Capital | - | - | - | - | - | - | 0 | 0 | 40 | 40 |
| Debts | - | - | - | - | - | - | 165.616 | 156.986 | 119.946 | 313.731 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharmaprix Distribution S.r.l.